Business Market Segments

Business Investor Potential

Principal market segments offer a multi-billion-dollar revenue return. Modest penetration rates will yield substantial revenues.

Public Health represents key sub-segments encompassing  venues where large numbers of  people congregate including casinos, hotels, cruise ships, airports, airplanes, health-care facilities, malls and retailers,  government facilities,  universities, schools, sports  arenas and restaurants and  religious facilities. ISS  LLC’s proven results are  available for review.

We are particularly focused on the medical and health care industry.

ISS LLC’s technology  can protect closed  environments against viral  infections, reduce the need  for antibiotics and is proven  to increase general health  and weight of farmed  animals.

ISS LLC’s topical cream  platform will also be  extended to help manage  harmful and even debilitating  skin conditions in livestock  and pets.

ISS LLC’s Poultry Protection technology has proven increases in weight gain, reduced flock loss, better grain usage, reduced insect infestation and substantial reduction in ammonia odor.

In the Plant Health segment, key sub-segments are based on the

largest individual commercial crops.  Apart from extensive successful  increased yields, ISS LLC’s technology has also been  used to control fungi in grain silos  with outstanding results.

ISS LLC’s technology offers a  chemical free solution for cannabis  growers controlling harmful  mephitic organisms such as molds,  bacteria and yeasts.

A two-year trial with USAID produced average yield increases of 70+% in numerous crops.

ISS LLC’s spectacular  efficacy opens up a range of  possibilities in many multi-  billion dollar cosmetic as well as medical skin treatment markets, livestock and pet markets. In multiple global testing ISS LLC’s proprietary formulation has  been effective in managing a  virtually endless array of skin  problems, without  negative side effects.

This breakthrough technology provides non-prescription results far superior to prescribed medications in a shorter time frame. Our unique cellular matrix, proprietary compound is unmatched for results.

Each of ISS LLC’s principal segments houses a diverse range of recognized sub-segments, that  permit targeted, refined and cost-effective marketing and distribution strategies leading to substantial revenue returns.

All Are Nobel Prize Nominated Technologies

Indoor Environment Market Potiential

$800 Billion

USA MARKET OPPORTUNITY

$ Boundless

GLOBAL MARKET OPPORTUNITY

HOSPITALS

SCHOOLS

GOVERNMENT BUILDINGS

CORPORATIONS

AIRPORTS

CRUISE LINES

FITNESS CENTERS

SHOPPING MALLS

HOTELS & CASINOS

CLEANING
     & SANITATION COMPANIES

Agriculture & Animal Market Potential

$12 Billion

USA MARKET OPPORTUNITY

$60 Billion

GLOBAL MARKET OPPORTUNITY

CATTLE FARMS

DAIRY FARMS

POULTRY FARMS

FORESTRY

FRUIT PRODUCTION

CASH CROPS

TROPICAL FRUIT & VEGETABLES

FARM ANIMAL SKIN CONDITIONS

PET SKIN HEALTH & ODOR CONTROL

FOOD TRANSPORTATION

FOOD STORAGE

SEED PRODUCTION & STORAGE

OTC Skincare Market Potential

  • ISS LLC has launched a new division based on breakthrough topical skin technology developed by Dr. Martin and ISS LLC which offers remarkable potential in safely dealing with an expansive range of conditions such as  acne, rosacea, eczema, insect bites, burns, scrapes, cuts and more serious wounds, diaper rash, incontinence-related issues, athlete’s foot, vaginitis, ringworm and even pain relief. 
  • All active ingredients are Certified Organic Input and/or on acceptable FDA, EPA or USDA lists. The IP is protected.  Dr. Martin spent over 8 years developing this topical skin technology, testing a variety of complex compounding  processes to get the line to the commercialization stage.
  • ISS LLC has merged the various solutions with effective application modes including sprays, lotions, creams,  serums, patches and roll-ons.

Unique Proprietary Characteristics

  • Nobel Prize Nominated technology 
  • Proprietary Phyto-Active cellular matrix
  • Hyaluronic Acid-Free yet more effective
  • No animal testing
  • Superior dermal penetration and hydration
  • Superior non-prescription skin problem efficacy available
  • Hypoallergenic
  • Accelerated skin repair and rejuvenation
  • Tone, texture and smoothness enhancement

Topical Skin Division Strategy

  • ISS LLC intends a targeted initial roll-out of its all- purpose skin serum with select dermatologists and  cosmetic surgeons, and then through select distributors on the OTC market.

  • In parallel, the team will be conducting all necessary testing to enable marketing claims and the widest distribution possible.

  • In select segments, ISS LLC will seek to joint venture or license its technology with market leaders seeking a new break-through product and technology.

  • Promising initial JV/licensing segment opportunities include babies and general and post-surgical wound healing.

Industry Projections for Market Potential in Skincare

 

USA MARKET OPPORTUNITY

2024 Market Value      $30.01 Billion

2030 Market Value      $39.81 Billion

GLOBAL MARKET OPPORTUNITY

2024 Market Value      $146.7 Billion

2030 Market Value      $244.8 Billion

Innovative Scientific Solutions.

Address

500 S. Federal Highway, Ste 3925
Hallandale Beach, FL 33008

Phone

(843) 368-7063
(704) 280-6551

Sustainable Enhancements for Human Health and Wellness through Nobel Prize Nominated Technology.

Copyright © 2025 Divi. All Rights Reserved.